Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057105274904v1
10/5/427    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kool, J.
Right arrow Articles by Vermeulen, N. P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kool, J.
Right arrow Articles by Vermeulen, N. P. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Development of a Novel Cytochrome P450 Bioaffinity Detection System Coupled Online to Gradient Reversed-Phase High-Performance Liquid Chromatography

Jeroen Kool

Sebastiaan M. van Liempd

Rawi Ramautar

LACDR-Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit, Amsterdam, the Netherlands.

Tim Schenk

Kiadis B.V., Groningen, the Netherlands.

John H. N. Meerman

LACDR-Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit, Amsterdam, the Netherlands.

Hubertus Irth

Kiadis B.V., Groningen, the Netherlands.

Jan. N. M. Commandeur

Nico P. E. Vermeulen

LACDR-Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit, Amsterdam, the Netherlands.

A high-resolution screening platform, coupling online affinity detection for mammalian cytochrome P450s (Cyt P450s) to gradient reversed-phase high-performance liquid chromatography (HPLC), is described. To this end, the onlineCyt P450 enzyme affinity detection (EAD) system was optimized for enzyme (ß-NF-induced rat liver microsomes), probe substrate (ethoxyresorufine), and organic modifier (methanol or acetonitrile). The optimized Cyt P450 EAD system has first been evaluated in a flow injection analysis (FIA) mode with 7 known ligands of Cyt P450 1A1/1A2 (ß-naphthoflavone, ßnaphthoflavone, ellipticine, 9-hydroxy-ellipticine, fluvoxamine, caffein, and phenacetin). Subsequently, IC 50 valueswere online in FIA-mode determined and compared with those obtained with standardmicrosomal assay conditions. The IC 50 values obtained with the online Cyt P450 EAD system agreed well with the IC 50 values obtained in the standard assays. For highaffinity ligands ofCyt P450 1A1/1A2, detection limits of 1 to 3 pmol injected (n= 3; signal to noise [S/N] = 3) were obtained. The individual inhibitory properties of ligands in mixtures of the ligands were subsequently investigated using an optimized Cyt P450 EAD system online coupled to gradient HPLC. Using the integrated online gradient HPLC Cyt P450 EAD platform, detection limits of 10 to 25 pmol injected (n= 1; S/N= 3) were obtained for high-affinity ligands. It is concluded that this novel screening technology offers new perspectives for rapid and sensitive screening of individual compounds in mixtures exhibiting affinity for liver microsomal Cyt P450s.

Key Words: cytochrome P450 • online bioaffinity assay • high-resolution screening (HRS) • fluorescence • enzyme affinity detection (EAD)

This version was published on August 1, 2005

Journal of Biomolecular Screening, Vol. 10, No. 5, 427-436 (2005)
DOI: 10.1177/1087057105274904


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
J. Kool, A. Van Marle, S. Hulscher, M. Selman, D. J. Van Iperen, K. Van Altena, M. Gillard, R. A. Bakker, H. Irth, R. Leurs, et al.
A Flow-Through Fluorescence Polarization Detection System for Measuring GPCR-Mediated Modulation of cAMP Production
J Biomol Screen, December 1, 2007; 12(8): 1074 - 1083.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Kool, S. M. van Liempd, H. van Rossum, D. A. van Elswijk, H. Irth, J. N. M. Commandeur, and N. P. E. Vermeulen
Development of Three Parallel Cytochrome P450 Enzyme Affinity Detection Systems Coupled On-line to Gradient High-Performance Liquid Chromatography
Drug Metab. Dispos., April 1, 2007; 35(4): 640 - 648.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
J. Kool, M. Eggink, H. van Rossum, S. M. van Liempd, D. A. van Elswijk, H. Irth, J. N.M. Commandeur, J. H.N. Meerman, and N. P.E. Vermeulen
Online Biochemical Detection of Glutathione-S-Transferase P1-Specific Inhibitors in Complex Mixtures
J Biomol Screen, April 1, 2007; 12(3): 396 - 405.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
S. M. van Liempd, J. Kool, W. M. A. Niessen, D. E. van Elswijk, H. Irth, and N. P. E. Vermeulen
On-line Formation, Separation, and Estrogen Receptor Affinity Screening of Cytochrome P450-Derived Metabolites of Selective Estrogen Receptor Modulators
Drug Metab. Dispos., September 1, 2006; 34(9): 1640 - 1649.
[Abstract] [Full Text] [PDF]